In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months ...
Relapse, or recurrence, occurs when multiple myeloma symptoms return, such as bone pain, fatigue, and kidney problems. It’s possible to live for many years after a relapse of multiple myeloma. Outlook ...
Early treatment with high-efficacy MS drugs cut the risk of relapse, but not disability progression independent of relapse ...
Interleukin-23 inhibitors, prior treatment history, and Psoriasis Area and Severity Index scores may be predictive of time to disease relapse among patients with psoriasis who achieved clinical ...
It is possible for leukemia to relapse after 20 years. However, it is much more likely for leukemia to relapse in the first few years after the initial diagnosis or remission. Some research reports ...
Please provide your email address to receive an email when new articles are posted on . Among patients with first-episode psychosis, the effectiveness of antipsychotics for relapse prevention ...
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the publication of efficacy ...
Bottom Line: In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results